Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MabThera in Rheumatoid Arthritis (RESONAR)
NCT01117129Phase 4Terminated
- Sponsor
- Roche
- Start
- Apr 2010
- Primary completion
- Jun 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of rituximab in rheumatoid arthritis (RA), sponsored by Roche. Started Apr 2010; status: terminated.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01117129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01117129.